Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies

  title={Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies},
  author={Cristiano Andr{\'e} K{\"o}hler and Thiago Holanda Freitas and Michael Maes and Nayanna Quezado de Andrade and C. Liu and Brisa Fernandes and Brendon Stubbs and Marco Solmi and Nicola Veronese and Nathan Herrmann and Charles L. Raison and Barbara J. Miller and Krista L. Lanct{\^o}t and Andr{\'e} Ferrer Carvalho},
  journal={Acta Psychiatrica Scandinavica},
To conduct a systematic review and meta‐analysis of studies that measured cytokine and chemokine levels in individuals with major depressive disorder (MDD) compared to healthy controls (HCs). 

Exploring Links between Melatonin, Inflammation and Depression

A large number of the patients with MDD do not experience a remission with current treatments, and the need for new and innovative treatments to treat the condition is urgently needed.

Research Paper: The Association of Depressive Symptoms With Plasma C-Reactive Protein in Patients With Major Depressive Disorder Under Treatment

The next generation of smart grids will be able to store and share information about smart grids, as well as provide real-time information about how to connect and manage them.

Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years

It is investigated whether the aspirin use is associated with a decreased incidence of depressive symptoms in a large North American cohort.

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis

An updated meta-analysis of studies that measured peripheral levels of cytokines and chemokines during antidepressant treatment in patients with MDD indicates that antidepressants decrease several markers of peripheral inflammation, but does not provide evidence that reductions in peripheral inflammation are associated with antidepressant treatment response.

Metabolomic profiles discriminating anxiety from depression

This work investigated whether differential metabolomic alterations are present between anxiety and depressive disorders and which clinical characteristics of these disorders are related to metabolomic alteration.

Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis

Overall, the meta-analysis finds evidence linking abnormalities of blood chemokines with depression in humans and demonstrates the possibility of classifying individuals with depression based on their inflammatory biomarker profile.

Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis

It is suggested that alterations in peripheral cytokine levels were associated with antidepressant treatment outcomes in MDD.

Cytokine Research in Depression: Principles, Challenges, and Open Questions

Cytokines might not be associated with the diagnosis of depression according to the currently used diagnostic manuals, but rather with specific subtypes of depression, or with depressive symptoms across different psychiatric diagnoses, therefore the currently available diagnostic systems may not be the ideal starting point for psychiatric cytokine research.



Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies

A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression

Overall, there were similarities in the pattern of cytokine alterations in schizophrenia, bipolar disorder and MDD during acute and chronic phases of illness, raising the possibility of common underlying pathways for immune dysfunction.

Cytokine Production and Serum Proteins in Depression

The results suggest that the increase in immune activity seen at the beginning of the study may be followed by a suppressed cell‐mediated immune function.

Meta-Analysis of Cytokines and Chemokines in Suicidality: Distinguishing Suicidal Versus Nonsuicidal Patients

A Meta-Analysis of Cytokines in Major Depression

Cumulative meta-analysis of interleukins 6 and 1 beta , tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder

This cumulative meta-analysis confirmed higher mean levels of interleukin-6 and C-reactive protein in patients with major depression compared to non-depressed controls and no consistent association between tumour necrosis factor-a, interleukain-1b and major depression was observed.

Melancholic and atypical major depression — Connection between cytokines, psychopathology and treatment

Integrating neuroimmune systems in the neurobiology of depression

Interventions targeting immune-related cellular and molecular pathways may benefit subsets of MDD patients with immune dysregulation and ongoing studies examining neuroimmune mechanisms that influence neuronal activity as well as synaptic plasticity are discussed.

Fluoxetine treatment for major depression decreases the plasma levels of cytokines

Findings suggest that MDD is associated with activation of the immune system, and the antidepressant effect of fluoxetine may be mediated in part through its anti-inflammatory effects.